DMTC’s program and project management framework is a key element in delivering value to our stakeholders and was validated in our achievement of ISO 9001 accreditation for our quality system.
We constantly review the performance of our processes and the level of engagement of our project leaders so that what we do remains not just value adding but fit-for-purpose as we adapt to changes in the business environment.
Our recent survey of project leaders showed excellent levels of engagement. Click here for a look at some of the headline results.
The national significance of DMTC’s Medical Countermeasures (MCM) Program, bringing industry and research partners together to work on national health security challenges, has been highlighted in the latest in the series of Defence Science & Technology Outlook publications. (more…)
Federal Member for Ryan, the Hon Jane Prentice MP, used a speech in Federal Parliament earlier this year to publicly acknowledge the career of one of the founding fathers of DMTC, Emeritus Professor David St.John from the University of Queensland.
You can watch Mrs Prentice’s speech here.
The recognition in Federal Parliament followed David’s acceptance, earlier this year, of one of three inaugural DMTC Fellowships for significant meritorious contributions to the company.
In March 2019 a symposium named in Professor St John’s honour will be held at the international TMS 2019 conference in Texas. TMS brings together more than 4,000 engineers, scientists, business leaders and other professionals in the minerals, metals and materials disciplines.
DMTC Limited has announced the commencement of a new project under Round Three of its Medical Countermeasures Program. The project will advance the development of a new Australian antibiotic by partnering its developer, Boulos & Cooper Pharmaceuticals, with manufacturing experts from CSIRO. (more…)
